SCHEMBL22844978

SCHEMBL22844978

NCCOCCOCCOCCNC(=O)c1cc(NC(=O)CBr)cc(NC(=O)CBr)c1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ CA2 P00918 6/20 0.43
▸ HDAC3 O15379 1/20 0.38
▸ HDAC1 Q13547 1/20 0.38
▸ CA12 O43570 2/20 0.38
▸ CA1 P00915 2/20 0.38
▸ CA4 P22748 2/20 0.38
▸ CA9 Q16790 2/20 0.38
▸ CA14 Q9ULX7 2/20 0.38
▸ ALB P02768 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.34
▸ NPC1 O15118 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ NAMPT P43490 1/20 0.33
▸ PLAU P00749 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22844929 0.88 SMN1; SMN2 (0.46) SMN1; SMN2CA2HDAC3HDAC1CA12
SCHEMBL22844962 0.87 SMN1; SMN2 (0.44) SMN1; SMN2CA2HDAC3HDAC1CA12
SCHEMBL29531140 0.83 CRBN (0.41) SMN1; SMN2CA2HDAC3HDAC1CA12
SCHEMBL22845092 0.81 HDAC3 (0.46) SMN1; SMN2CA2HDAC3HDAC1NPC1
SCHEMBL17039696 0.77 SMN1; SMN2 (0.48) SMN1; SMN2CA2HDAC3HDAC1NAMPT
SCHEMBL24796096 0.75 MEN1 (0.40) SMN1; SMN2CA2HDAC3HDAC1CA12
SCHEMBL15757525 0.75 MEN1 (0.40) SMN1; SMN2CA2HDAC3HDAC1CA12
SCHEMBL17841946 0.74 MEN1 (0.37) SMN1; SMN2CA2HDAC3HDAC1CA12
SCHEMBL21142116 0.74 SMN1; SMN2 (0.66) SMN1; SMN2CA2HDAC3HDAC1NPC1
SCHEMBL16619189 0.73 SMN1; SMN2 (0.57) SMN1; SMN2HDAC3HDAC1ALBNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020260514-A1 BIS(2-HALOACETAMIDO)-COMPOUNDS FOR USE AS LINKING AGENTS AND RESULTANT PRODUCTS WHICH COMPRISE ANTIBODIES, HALF-ANTIBODIES AND ANTIBODY FRAGMENTS THE UNIVERSITY OF BATH (GB) 2020-12-30 — — WO disclosed
Send feedback